JP2005529152A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529152A5 JP2005529152A5 JP2004505078A JP2004505078A JP2005529152A5 JP 2005529152 A5 JP2005529152 A5 JP 2005529152A5 JP 2004505078 A JP2004505078 A JP 2004505078A JP 2004505078 A JP2004505078 A JP 2004505078A JP 2005529152 A5 JP2005529152 A5 JP 2005529152A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- dose
- antibody
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- 102100024484 Codanin-1 Human genes 0.000 claims 2
- 101000980888 Homo sapiens Codanin-1 Proteins 0.000 claims 2
- 102000008070 Interferon-gamma Human genes 0.000 claims 2
- 108010074328 Interferon-gamma Proteins 0.000 claims 2
- 229960003130 interferon gamma Drugs 0.000 claims 2
- 238000011282 treatment Methods 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 102000043557 human IFNG Human genes 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15074202A | 2002-05-17 | 2002-05-17 | |
| US38331002P | 2002-05-22 | 2002-05-22 | |
| PCT/US2003/015874 WO2003097082A2 (en) | 2002-05-17 | 2003-05-16 | Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005529152A JP2005529152A (ja) | 2005-09-29 |
| JP2005529152A5 true JP2005529152A5 (enrdf_load_stackoverflow) | 2006-07-06 |
Family
ID=29552737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004505078A Pending JP2005529152A (ja) | 2002-05-17 | 2003-05-16 | 抗インターフェロンγ抗体を用いたクローン病又は乾癬の治療 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1506002A4 (enrdf_load_stackoverflow) |
| JP (1) | JP2005529152A (enrdf_load_stackoverflow) |
| AU (1) | AU2003231802A1 (enrdf_load_stackoverflow) |
| CA (1) | CA2486147A1 (enrdf_load_stackoverflow) |
| WO (1) | WO2003097082A2 (enrdf_load_stackoverflow) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE173630T1 (de) | 1992-12-29 | 1998-12-15 | Genentech Inc | Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren |
| WO2006109191A2 (en) | 2005-01-27 | 2006-10-19 | Novimmune S.A. | Human anti-interferon gamma antibodies and methods of use thereof |
| WO2007121491A1 (en) * | 2006-04-25 | 2007-11-01 | Intercell Ag | Hcv vaccinations |
| EP2274333A4 (en) * | 2008-03-18 | 2011-06-15 | Abbott Lab | PROCESS FOR TREATING PSORIASIS |
| WO2013078378A1 (en) | 2011-11-23 | 2013-05-30 | Amgen Inc. | Methods of treatment using an antibody against interferon gamma |
| MA41271A (fr) * | 2014-12-26 | 2017-10-31 | Celgene Alpine Invest Company Ii Llc | Méthodes d'utilisation d'oligonucléotides antisens ciblant smad7 |
| IL282923B2 (en) | 2015-05-07 | 2023-10-01 | Novimmune Sa | Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of cxcl9 and other biomarkers |
| US11091543B2 (en) | 2015-05-07 | 2021-08-17 | Swedish Orphan Biovitrum Ag | Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| ATE356869T1 (de) | 1990-01-12 | 2007-04-15 | Amgen Fremont Inc | Bildung von xenogenen antikörpern |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| CA2124967C (en) | 1991-12-17 | 2008-04-08 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
| ATE173630T1 (de) * | 1992-12-29 | 1998-12-15 | Genentech Inc | Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren |
| CA2297692A1 (en) * | 1997-08-18 | 1999-02-25 | Innogenetics N.V. | Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders |
| JP2002531466A (ja) * | 1998-12-01 | 2002-09-24 | プロテイン デザイン ラブス， インコーポレイテッド | γ−インターフェロンに対するヒト化抗体 |
| US20050019323A1 (en) * | 2002-05-22 | 2005-01-27 | Protein Design Labs, Inc. | Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies |
-
2003
- 2003-05-16 WO PCT/US2003/015874 patent/WO2003097082A2/en active Application Filing
- 2003-05-16 CA CA002486147A patent/CA2486147A1/en not_active Abandoned
- 2003-05-16 EP EP03753102A patent/EP1506002A4/en not_active Withdrawn
- 2003-05-16 JP JP2004505078A patent/JP2005529152A/ja active Pending
- 2003-05-16 AU AU2003231802A patent/AU2003231802A1/en not_active Abandoned